Structures by: Okmanov R. Y.
Total: 14
1-Isobutyl-8,9-dimethoxy-3-phenyl-5,6-dihydroimidazo[5,1-<i>a</i>]isoquinolin-2-ium chloride
C23H27N2O2,Cl
IUCrData (2019) 4, 10 x191390
a=13.595(3)Å b=14.337(3)Å c=10.958(2)Å
α=90.00° β=92.23(3)° γ=90.00°
2-(4-Bitrobenzoyloxy)acetamide 4-Nitro-benzoic acid carbamoylmethyl ester
C9H8N2O5
Acta Crystallographica Section E (2020) 76, 12 1805-1809
a=7.1238(14)Å b=7.3683(15)Å c=10.063(2)Å
α=107.82(3)° β=94.95(3)° γ=96.32(3)°
2-(4-Aminobenzoyloxy)acetamide monohydrate 4-Aminobenzoic acid carbamoylmethyl ester monohydrate
C9H10N2O3,H2O
Acta Crystallographica Section E (2020) 76, 12 1805-1809
a=8.2431(16)Å b=4.8088(10)Å c=26.754(5)Å
α=90° β=90.10(3)° γ=90°
2,3-Dimethoxy-5,6,7,8,13,13a-hexahydro-6a,8-diazaindeno[2,1-<i>b</i>]phenanthrene methanol monosolvate
C21H22N2O2,C1H4O1
Acta Crystallographica Section E (2015) 71, 8 o574-o575
a=7.6080(3)Å b=11.8061(5)Å c=12.3327(5)Å
α=65.242(4)° β=73.956(4)° γ=75.724(4)°
1-[(4-<i>tert</i>-Butylphenyl)sulfonyl]-1<i>H</i>-benzimidazole
C17H18N2O2S
Acta Crystallographica Section E (2011) 67, 3 o709
a=12.142(2)Å b=8.8940(18)Å c=15.324(3)Å
α=90.00° β=96.78(3)° γ=90.00°
2,3-gexamethylene-3,4-dihydroquinazolin-4-one
C14H16N2O
Acta Crystallographica Section E (2009) 65, 8 o1776
a=9.5490(19)Å b=10.584(2)Å c=11.693(2)Å
α=90.00° β=90.00° γ=90.00°
9-Furfurylidene-2,3-dimethyl-6,7,8,9-tetrahydro-4<i>H</i>-thieno[2',3':4,5]pyrimidino[1,2-<i>a</i>]pyridin-4-one
C17H16N2O2S
Acta Crystallographica Section E (2010) 66, 3 o552-o553
a=16.569(3)Å b=11.034(2)Å c=8.2775(17)Å
α=90.00° β=93.12(3)° γ=90.00°
11-(2-Oxopyrrolidin-1-ylmethyl)-1,2,3,4,5,6,11,11a-octahydropyrido[2,1-<i>b</i>]quinazolin-6-one dihydrate
C17H21N3O2,2(H2O)
Acta Crystallographica Section E (2010) 66, 4 o890
a=14.794(3)Å b=7.6720(15)Å c=15.593(3)Å
α=90.00° β=104.48(3)° γ=90.00°
(<i>E</i>)-3-[4-(Dimethylamino)benzylidene]-2,3-dihydro- 1<i>H</i>,9<i>H</i>-pyrrolo[2,1-<i>b</i>]quinazolin-9-one
C20H19N3O
Acta Crystallographica Section E (2010) 66, 7 o1592
a=8.8030(18)Å b=16.415(3)Å c=11.463(2)Å
α=90.00° β=105.05(3)° γ=90.00°
2-Methyl-4-oxo-6,7,8,9-tetrahydrothieno[2',3':4,5]pyrimidino[1,2- <i>a</i>]pyridine-3-carboxylic acid
C12H12N2O3S
Acta Crystallographica Section E (2011) 67, 4 o824
a=7.2550(15)Å b=20.506(4)Å c=15.824(3)Å
α=90.00° β=96.93(3)° γ=90.00°
3-Methyl-2-(3,3,3-trichloro-2-hydroxypropyl)quinazolin-4(3<i>H</i>)-one
C12H11Cl3N2O2
Acta Crystallographica Section E (2013) 69, 7 o1094
a=9.3440(19)Å b=11.352(2)Å c=25.719(5)Å
α=90.00° β=90.00° γ=90.00°
2-<i>n</i>-Butyl-6-chloro-1-(2,4-dimethylphenylsulfonyl)-1<i>H</i>- benzimidazole--2-<i>n</i>-butyl-5-chloro-1-(2,4-dimethylphenylsulfonyl)- 1<i>H</i>-benzimidazole (0.759/0.241)
0.759(0.241C19H21ClN2O2S),0.241(0.241C19H21ClN2O2S)
Acta Crystallographica Section E (2011) 67, 12 o3345-o3346
a=8.7340(17)Å b=10.251(2)Å c=11.390(2)Å
α=71.29(3)° β=78.38(3)° γ=76.75(3)°
<i>N</i>-(5-Benzylsulfanyl-1,3,4-thiadiazol-2-yl)-2-(piperidin-1-yl)acetamide
C16H20N4OS2
Acta Crystallographica Section E (2014) 70, 3 o241
a=17.429(4)Å b=16.748(3)Å c=5.8390(12)Å
α=90.00° β=95.48(3)° γ=90.00°
(2-(4-Bromobenzoyloxy)acetamide) 4-Bromo-benzoic acid carbamoylmethyl ester
C9H8BrNO3
Acta Crystallographica Section E (2020) 76, 12 1805-1809
a=18.623(4)Å b=4.8255(10)Å c=23.195(5)Å
α=90° β=112.96(3)° γ=90°